Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Plataforma ISCIII de soporte para la Investigación Clínica

IP: Inmaculada Fuentes Camps
Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Plataforma ISCIII de soporte para la Investigación Clínica , Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Joan Genescà Ferrer, Paula Isabel Roldan Caballero
Funding agency: Instituto de Salud Carlos III
Funding: 315150
Reference: PT20/00078
Duration: 01/01/2021 - 31/12/2024

T2CogVR - Structural and functional brain changes as a proxy for Virtual Reality cognitive training efficacy in Type 2 Diabetes Mellitus elderly patients

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació "La Caixa"
Funding: 92327.22
Reference: SR20-00730
Duration: 01/02/2021 - 30/09/2024

Bloqueo intraocular de la hemopexina: una nueva estrategia para tratar el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: Hugo Ramos Abellan, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 78100
Reference: DTS19/00171
Duration: 01/01/2020 - 31/12/2021

Incidència de complicacions de l'accés venós perifèric en la població diabètica tipus 2. Anàlisi dels factors de risc i estudi comparatiu de dos dispositius perifèrics.

IP: Rafael Simó Canonge
Collaborators: Marc Rivas Agudo, Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 73343.84
Reference: SLT008/18/00104
Duration: 01/07/2019 - 20/03/2021

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Jordi Tomás Hernández

Jordi Tomás Hernández

Reconstructive Surgery of the Locomotor System
Read more
Eva Gavilan  Castillo

Eva Gavilan Castillo

Main researcher
Multidisciplinary Nursing Research Group
Read more
Juan Pedro Barret Nerín

Juan Pedro Barret Nerín

Main researcher
Donation and transplantation of organs, tissues and cells
Read more
Miquel Casas Brugué

Miquel Casas Brugué

Senior researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.